Summary of "항생제를 자주 먹으면 매우 위험한 이유는? 감염내과 의사가 알려주는 항생제 내성 ｜최원석 교수｜고대백과 EP 06"

Main ideas, concepts, and lessons

Antibiotic resistance is a major global threat
- By around 2050, it’s estimated ~10 million people worldwide will die each year due to antibiotic-resistant infections (≈ one person every three seconds).
- Antibiotic-resistant bacteria are already causing substantial deaths today (reported ~1.2 million deaths globally at present).
- The speaker emphasizes that antibiotic resistance may cause more deaths than other major causes (e.g., cancer or traffic accidents).
Common public misuse of antibiotics is widespread in Korea
- A 2022 survey on antibiotic resistance awareness found that three out of four Koreans misunderstand how antibiotics should be used.
Why antibiotics don’t help for many illnesses
- Antibiotics primarily work against bacteria, not against other pathogens.
- Therefore, using antibiotics for illnesses like the common cold is often ineffective.
Core mechanism: “selective pressure”
- Normally, bacteria exposed to antibiotics should either:
  - have their growth inhibited, or
  - die.
- When bacteria become resistant, they survive and keep multiplying despite antibiotic exposure.
- The fundamental driver is selective pressure:
  - Antibiotics kill susceptible bacteria.
  - Resistant bacteria survive, then multiply and spread.
- This selective advantage is what allows resistant strains to become dominant.
Why antibiotic resistance is particularly serious in Korea
- High antibiotic usage in humans
  - In 2011, Korea ranked 3rd among OECD countries for human antibiotic use.
  - The speaker suggests Korea’s high-quality healthcare and access increases antibiotic prescribing opportunities.
- Hospital transmission dynamics
  - Hospital layouts often involve multi-room wards.
  - Resistant bacteria can spread more easily via contact, especially with frequent contact and high temperatures.
  - This increases chances that hospitalized patients acquire resistant bacteria.
- Use in non-human sectors (livestock/agriculture)
  - Citing Science (2017): antibiotic usage related to livestock production in Korea was 1–6 times higher than in some countries (example mentioned: Japan, Denmark), and the trend is reportedly increasing.
- Ecosystem perspective (“One Health”)
  - Antibiotic resistance emerges across the human-animal-environment ecosystem.
  - Resistance in animals can eventually affect humans.
Misconceptions about “superbugs” and resistance
- The public may think that if someone has resistant bacteria, everyone must take medication.
- The media term “superbug” (often meaning multidrug-resistant bacteria) can be misleading.
- The speaker explains resistance does not always make bacteria “unstoppable” in a literal sense; bacteria in their natural state can be different in traits.
Resistance is not always permanent
- Without antibiotics (removing selective pressure), non-resistant bacteria may have a survival advantage.
- Over time, if resistant bacteria face no antibiotic pressure, the resistant population can decline—potentially allowing isolation precautions to be lifted.
- However, it’s difficult when patients with resistance are often:
  - elderly, and/or
  - have multiple underlying diseases requiring frequent hospital visits,
  - meaning resistance tends to persist rather than quickly disappear.
Why new antibiotics can’t be “just invented”
- Developing antibiotics takes a lot of time and money.
- Even after development, if they are used carefully, resistance doesn’t emerge easily—so:
  - antibiotics may not generate long-term profits.
- Pharmaceutical companies may therefore have less incentive to develop new antibiotics.
- Raising drug prices is argued to not be an easy or fair solution, because those most likely harmed economically by high prices include:
  - people with chronic illnesses,
  - long-term infectious disease patients,
  - those facing financial hardship.

Prevention and management approach (methodology / instructions in bullet form)

Reduce antibiotic resistance by reducing unnecessary antibiotic use

Use antibiotics only when truly needed
- Antibiotics are lifesaving, so they must be prescribed to those who need them.
- The key priority is minimizing inappropriate antibiotic use.
Institutional and policy actions
- Promote Antibiotic Resistance Awareness Week-type initiatives.
- Include antibiotic-resistance and antibiotic-management practices in quality assessments for medical institutions.
- Government/public bodies should support:
  - research funding, and
  - streamlined or facilitated approval processes for new antibiotics (the speaker notes the National Assembly role).

Continue developing new drugs, but recognize incentives are a challenge

Maintain ongoing efforts to develop new antibiotics.
Adjust incentives and support systems so development remains feasible.

Use vaccination to reduce infections and thus reduce antibiotic demand

Vaccination (properly administered) helps by:
- lowering the risk of infection, and
- reducing the chance of infection progressing to severe disease.
Less severe illness generally means fewer antibiotic prescriptions.

Individual behavior: use antibiotics appropriately and understand “colds”

Recognize that most colds are viral and are handled by the immune system.
“Medicine vs. time” idea clarified:
- Taking medicine doesn’t necessarily shorten total illness length.
- It mainly helps alleviate symptoms and makes recovery more manageable.
For “cold-like” symptoms:
- Don’t assume it’s always a cold—different diseases can look similar.
- Influenza and COVID-19 have antiviral treatments.
- Antiviral drugs work best when started early (soon after symptoms begin) to:
  - shorten illness duration, and
  - reduce complications.
Practical guidance given by the speaker:
- If it’s clearly a simple cold, you may not need hospital treatment or antibiotics.
- But you should seek medical evaluation to distinguish from illnesses like influenza/COVID-19 and identify cases where early medication is beneficial.

Speakers / sources featured

Speaker / source person

최원석 교수 (Wonseok Choi) — Department of Infectious Diseases, Korea University (infectious disease specialist; conducts research on vaccines, epidemiology/policy of infectious diseases, infection control, antibiotic resistance, and treats patients)

Named sources / external references

2022 survey on antibiotic resistance awareness (Korea-focused)
OECD countries (comparison for antibiotic usage)
Science (2017) — data about antibiotic usage in Korea relative to livestock production and other countries